Collaborating To Tighten Timelines And Prepare For IND Filing

CCRM works with customers in a collaborative manner to enable them to accelerate the commercialization of new technologies. Our recent work with Nkarta Therapeutics is a great example.

Nkarta is a clinical-stage, cell therapy company focused on engineering natural killer (NK) cells for the treatment of cancer. As an emerging biotechnology company, Nkarta sought a contract development and manufacturing organization (CDMO) with a high degree of flexibility that could support its analytical development and manufacturing needs.

CCRM’s team is comprised of over 135 dedicated staff with years of experience in regenerative medicine, biopharmaceutical development and manufacturing. It had the extensive expertise Nkarta was looking for.